Autolus Therapeutics PLC Sustainability Reports

Autolus Therapeutics plc is a commercial-stage biopharmaceutical company that develops next-generation programmed T-cell therapies. The company primarily targets cancer and autoimmune diseases using its advanced cell programming technologies.

Sector: Manufacturing

Country: United Kingdom

Exchange: Nasdaq

LEI: 549300C0KZP8EYROLL02

FIGI: BBG00KVT06G6

13 reports from 2018 to 2025

• Autolus Therapeutics PLC 2025 Annual Report and Financial Statements
• Autolus Therapeutics PLC 2025 Gender Pay Gap
• Autolus Therapeutics PLC 2025 ESG Report
• Autolus Therapeutics PLC 2024 ESG Report
• Autolus Therapeutics PLC 2024 Annual Report and Financial Statements